NuVasive (NUVA:NASDAQ) Investor Relations Material

Overview

San Diego-based NuVasive Inc. is a medical technology company that designs, manufactures, and markets advanced procedural solutions for spine surgery. Among its product offerings are surgical access instruments like the Maxcess integrated split-blade retractor system, which reduces tissue disruption during spine surgery, and specialized spinal implants designed to enhance spinal fusion. NuVasive also offers cervical total disc replacement technology, neuromonitoring technology and services, and Pulse platform, a software ecosystem that integrates several hardware technologies into a single optimized footprint. Additionally, the company provides biologics to aid spinal fusion and bone healing, and Precice, an intramedullary device using the MAGEC technology to lengthen the femur and tibia non-invasively. The company distributes its products through independent sales agents, directly employed sales personnel, and distributors to patients, surgeons, hospitals, and insurers across the US and internationally. Incorporated in 1997, NuVasive has established a reputation as a leading global provider of innovative spinal surgical procedures.

Frequently Asked Questions

What is NuVasive's ticker?

NuVasive's ticker is NUVA

What exchange is NuVasive traded on?

The company's shares trade on the NASDAQ stock exchange

Where are NuVasive's headquarters?

They are based in San Diego, California

How many employees does NuVasive have?

There are 1001-5000 employees working at NuVasive

What is NuVasive's website?

It is nuvasive.com

What type of sector is NuVasive?

NuVasive is in the Healthcare sector

What type of industry is NuVasive?

NuVasive is in the Medical Instruments & Supplies industry

Who are NuVasive's peers and competitors?

The following five companies are NuVasive's industry peers:

- Sientra

- Merit Medical Systems

- Integra LifeSciences

- Insulet

- Stryker